MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
2 reports, 2 independent
Updated Wed 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cytokinetics
company in South San Francisco, United States
-
MarketBeat
American personal finance blog
-
Morgan Stanley
U.S. investment bank
Related events
- MarketBeat aggregated ratings and price targets for Goldman Sachs, while Morgan Stanley and Bank of America issued new research notes and price objectives.
- Morgan Stanley and Citigroup raised price targets on Appian Corporation, with MarketBeat aggregating the consensus data.
- Analyst firms RBC and Morgan Stanley set price targets for OTIS, with MarketBeat aggregating the ratings.
- MarketBeat is reporting on consensus targets and financial data for two companies: MarketBeat itself, and Alphabet Inc., noting both are communication services companies.
- MarketBeat reported that on August 1, Morgan Stanley issued an overweight rating and Bank of America issued a buy rating for Csquare.